Page 58 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 58

CHAPTER 2  Tumor Biology and Metastasis  37



                                             G0                 G1            Restriction point
                                     START
  VetBooks.ir                        Cytokinesis




                                   Telophase
                                               M                                   S
                                 Anaphase

                                 Metaphase


                                     Prophase

                                                                 G2
                                                                                 Cyclin B/CDK1
                                                                  Cyclin A/CDK2
                                       Cyclin E/CDK2
                                Cyclin D 1,2,3/CDK4,6


                       R



                  G1                        S                         G2                        M

                    G1/S
                                        E2F
                                                                                  Phosphorylation
                 Cells are stimulated
                  to enter cell cycle
                                                        pRB
                           • Fig. 2.1  The cell cycle and its control. The cell cycle is divided into four phases (G1, S, G2, and M)
                           and G0, which represents cycle-arrested cells. Cells are stimulated to enter the cell cycle in response to
                           external factors, including growth factors and cell adhesion molecules. During G1, cells are responsive to
                           mitogenic signals. Once the cell cycle has traversed the restriction point (R) in the G1 phase, the cell cycle
                           transitions become autonomous. Progression through the cell cycle is mediated by the sequential activa-
                           tion and inactivation of the cyclin-dependent kinases (CDKs). Control of CDK activity is through their inter-
                           action with specific cyclins (D, E, A, B) and with specific CDK inhibitors. G1-phase cyclin–CDK complexes
                           commit the cell to cell cycle entry at the G1/S transition through phosphorylation of pRb, causing release
                           of the E2F transcriptional factor and therefore an ability to overcome the Restriction point R and move into
                           the S-phase. After completion of S phase, M-phase cyclin–CDK complex activity rises and drives the cell
                           through the G2/M checkpoint by inducing chromosome condensation and creation of the mitotic spindle.

           requires phosphorylation by  CDK-activating kinases (CAKs);   causing release of the E2F transcriptional factor and therefore an
           meanwhile, the phosphorylation at threonine and serine residues   ability to overcome the restriction point R and move into the S
           suppresses activity. 11–16  CDKs are also tightly regulated by a class   phase. After completion of S phase, M-phase cyclin–CDK com-
           of inhibitory proteins known as CDK inhibitors (CDKIs). CDKIs   plex activity rises and drives the cell through the G2/M check-
           can block G1/S progression by binding CDKs/cyclin complexes   point by inducing chromosome condensation and creation of the
           and can be classified into two groups:                mitotic spindle. The corollary of all of these events is that loss of
             •   INK4A family (p15 INK4b , p16 INK4a , p18 INK4c , and p19 INK4d 13  these control mechanisms can be a driving event in the develop-
                                                           ).
               These act primarily on CDK4 and CDK6 complexes and     ment of cancer. 11–16  
               prevent the association with cyclin D.
             •   CIP/KIP family (p21 Cip1 , p27 Kip1 , and p57 Kip2 13  Cellular Responses to DNA Damage
                                                   ).  These are
               less specific and can inactivate various cyclin/CDK com-
               plexes.                                           Cancer  in  animals  and  people  is  a  common  disease;  however,
             G1-phase cyclin–CDK complexes commit the cell to cell cycle   considering the number of environmental stressors (that have the
           entry at the G1/S transition through phosphorylation of Rb,   potential to cause DNA damage) to which cells are exposed on
   53   54   55   56   57   58   59   60   61   62   63